Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis
H Li, XH Yu, X Ou, XP Ouyang, CK Tang - Progress in lipid research, 2021 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) is a quickly emerging global health problem
representing the most common chronic liver disease in the world. Atherosclerotic …
representing the most common chronic liver disease in the world. Atherosclerotic …
MicroRNA regulation of atherosclerosis
MW Feinberg, KJ Moore - Circulation research, 2016 - Am Heart Assoc
Atherosclerosis and its attendant clinical complications, such as myocardial infarction,
stroke, and peripheral artery disease, are the leading cause of morbidity and mortality in …
stroke, and peripheral artery disease, are the leading cause of morbidity and mortality in …
Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease
EM Maguire, SWA Pearce, Q Xiao - Vascular Pharmacology, 2019 - Elsevier
During atherosclerosis, the gradual accumulation of lipids into the subendothelial space of
damaged arteries results in several lipid modification processes followed by macrophage …
damaged arteries results in several lipid modification processes followed by macrophage …
Noncoding RNA s in disease
E Lekka, J Hall - FEBS letters, 2018 - Wiley Online Library
Noncoding RNA s are emerging as potent and multifunctional regulators in all biological
processes. In parallel, a rapidly growing number of studies has unravelled associations …
processes. In parallel, a rapidly growing number of studies has unravelled associations …
Non-coding RNAs: the new central dogma of cancer biology
The central dogma of molecular biology states that the functions of RNA revolve around
protein translation. Until the last decade, most researches were geared towards …
protein translation. Until the last decade, most researches were geared towards …
MicroRNAs in metabolism and metabolic disorders
V Rottiers, AM Näär - Nature reviews Molecular cell biology, 2012 - nature.com
MicroRNAs (miRNAs) have recently emerged as key regulators of metabolism. For example,
miR-33a and miR-33b have a crucial role in controlling cholesterol and lipid metabolism in …
miR-33a and miR-33b have a crucial role in controlling cholesterol and lipid metabolism in …
The role of the ATP-binding cassette A1 (ABCA1) in human disease
L Jacobo-Albavera, M Domínguez-Pérez… - International journal of …, 2021 - mdpi.com
Cholesterol homeostasis is essential in normal physiology of all cells. One of several
proteins involved in cholesterol homeostasis is the ATP-binding cassette transporter A1 …
proteins involved in cholesterol homeostasis is the ATP-binding cassette transporter A1 …
Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment
There is no consensus for a blood-based test for the early diagnosis of Alzheimer's disease
(AD). Expression profiling of small non-coding RNA's, microRNA (miRNA), has revealed …
(AD). Expression profiling of small non-coding RNA's, microRNA (miRNA), has revealed …
The emerging role of microRNAs in Alzheimer's disease
MicroRNAs (miRNAs) are small non-coding RNA which have been shown to regulate gene
expression. The alteration ofmiRNAs expression has been associated with several …
expression. The alteration ofmiRNAs expression has been associated with several …
MicroRNAs in metabolic disease
C Fernández-Hernando, CM Ramírez… - … , and vascular biology, 2013 - Am Heart Assoc
Alterations in the metabolic control of lipid and glucose homeostasis predispose an
individual to develop cardiometabolic diseases, such as type 2-diabetes mellitus and …
individual to develop cardiometabolic diseases, such as type 2-diabetes mellitus and …